Expression and Clinical Significance of Hepatocyte Growth Factor Activator Inhibitor Type 1 Gene in Prostatic Carcinoma

HU Chuan-yi,LIU Xiu-heng,GE Ming-huan,SONG Chao
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2012.04.063
2012-01-01
Abstract:Objective To investigate the expression and clinical significance of hepatocyte growth factor activator inhibitor type 1 ( HAI-1 ) gene in the tissues of prostatic carcinoma (PCa).Methods The prostate tissue specimens from 20 patients with benign prostate hyperplasia (BPH) and 48 patients with PCa were collected.Reverse transcription polymerase chain reaction ( RT-PCR ) and Western blotting were used to detect the expression of HAI-1 in these tissues.Results The positive expression rate of HAI-1 was 85.00% and 52.08% respectively in 20 cases of BPH and 48 cases of PCa tissues (P <0.05).The relative expression values of HAI-1 mRNA were 0.5482 ±0.0313 and 0.6718 ± 0.0516 respectively in PCa and BPH ( P < 0.05 ).The relative expression values of HAI-1 protein in PCa and BPH tissues were 0.5975 ± 0.0518 and 0.7039 ± 0.0377 respectively (P < 0.05 ).With the decrease in cellular differentiation and increase in the clinical staging,the expression of HAI-1 gene was decreased ( P < 0.05 ).The expression of HAI-1 gene in lymph node metastasis group was significantly lower than that in non-lymph node metastasis group (P < 0.05 ).Conclusion The HAI-1 gene deletion can be used as an important molecular marker in the invasion and metastasis of PCa.
What problem does this paper attempt to address?